Drug intelligence / Profile preview

colestipol

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Colestipol is a bile acid sequestrant used as an adjunct to diet and exercise to reduce elevated low-density lipoprotein (LDL) cholesterol levels in patients with primary hypercholesterolemia who do not respond adequately to dietary changes. It works by binding bile acid in the intestine, forming a complex that is excreted in the feces, thereby preventing their reabsorption. This process increases the oxidation of cholesterol to bile acids, upregulates hepatic LDL receptors, and enhances clearance of LDL from plasma, resulting in decreased serum total and LDL cholesterol levels. Colestipol is not systemically absorbed and may also be used for other conditions as determined by a healthcare provider[1][6][7].

Brand names
Colestid
Other names
colestipol hydrochloride

Beyond the preview

Go deeper on colestipol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colestipol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call